CAResearchers7- Cancer Research & Foundation

CAResearchers7- Cancer Research & Foundation Founded by Dr. Anoop Shaji | CAResearchers7 Foundation.

Alibaba Group Holding unveiled what it says is the world’s first artificial intelligence (AI) model to detect gastric ca...
13/07/2025

Alibaba Group Holding unveiled what it says is the world’s first artificial intelligence (AI) model to detect gastric cancer, even in early stages, by scanning computed tomography (CT) images.

Known as Grape – a name derived from “gastric cancer risk assessment procedure” – the system is a deep-learning framework that can analyse three-dimensional CT scans to detect and segment gastric cancer, also known as stomach cancer.

The system, following a similar innovation for pancreatic cancer, could change the screening approach globally, researchers say.

A new brain cancer treatment is showing remarkable early results. In a small clinical trial at Mass General Cancer Cente...
29/06/2025

A new brain cancer treatment is showing remarkable early results. In a small clinical trial at Mass General Cancer Center, three patients with aggressive glioblastoma saw their tumors shrink dramatically — some within just days — after receiving a single dose of an experimental cell therapy.
https://www.massgeneral.org/news/press-release/clinical-trial-results-show-dramatic-regression-of-glioblastoma-after-next-generation-car-t-therapy

A collaborative project by Mass General Cancer Center researchers to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.

The UK's National Health Service (NHS) is rolling out a new "super jab" for cancer treatment, specifically an injectable...
28/06/2025

The UK's National Health Service (NHS) is rolling out a new "super jab" for cancer treatment, specifically an injectable form of the immunotherapy drug Nivolumab, which can treat up to 15 different types of cancer. This new method allows patients to receive their treatment in just 5 minutes, significantly reducing the time compared to the previous hour-long IV drip. England is the first place in Europe to offer this new injection.

Thousands of patients will benefit from a new cancer jab for more than a dozen types of the disease, with the NHS the first in Europe to offer the new injection. The health service is rolling out an injectable form of immunotherapy, nivolumab, which means patients can receive their fortnightly or mo...

Cancers can be detected in the bloodstream three years prior to diagnosis, says study from ,  and  researchers.
20/06/2025

Cancers can be detected in the bloodstream three years prior to diagnosis, says study from , and researchers.

Cancers Can Be Detected in the Bloodstream Three Years Prior to Diagnosis 06/04/2025 Credit: iStock Fast Facts Click to Tweet Cancers can be detected in the bloodstream three years prior to diagnosis, says study from , and researchers. › Genetic mate...

Trial in China is one of the first times the immune therapy has worked against solid tumours.
06/06/2025

Trial in China is one of the first times the immune therapy has worked against solid tumours.

Trial in China is one of the first times the immune therapy has worked against solid tumours.

Researchers at the University of Minnesota have completed a landmark first-in-human clinical trial using CRISPR/Cas9 gen...
08/05/2025

Researchers at the University of Minnesota have completed a landmark first-in-human clinical trial using CRISPR/Cas9 gene editing to supercharge the immune system against aggressive gastrointestinal (GI) cancers.

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results, recently published in Lancet Oncology, show encouraging signs of safety and pote...

A small but heralded clinical trial at Memorial Sloan Kettering Cancer Center that saw re**al cancer disappear in 100% o...
26/01/2025

A small but heralded clinical trial at Memorial Sloan Kettering Cancer Center that saw re**al cancer disappear in 100% of people who took part has taken a step towards approval by the FDA.

Re**al cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.

KAIST research team led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering has developed a gro...
30/12/2024

KAIST research team led by Professor Kwang-Hyun Cho from the Department of Bio and Brain Engineering has developed a groundbreaking technology that can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side effects.

사이트 설명을 간략히 기록 해주세요.

Researchers have shown that they can accurately re-create clinical trials of new treatments using 'digital twins' of rea...
27/10/2024

Researchers have shown that they can accurately re-create clinical trials of new treatments using 'digital twins' of real cancer patients. The technology, called FarrSight®-Twin, is based on algorithms used by astrophysicists to discover black holes.

Friday 25 October 2024, Barcelona, Spain: Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital twins’ of real cancer patients. The technology, called FarrSight®-Twin, which is based on algorithms used by astrophysicists to discover black hol...

Researchers from Renmin Hospital of Wuhan University and Yale University found a new plant-based nanoparticle treatment ...
17/09/2024

Researchers from Renmin Hospital of Wuhan University and Yale University found a new plant-based nanoparticle treatment for glioblastoma, the fastest growing and most aggressive form of brain cancer.

A new nanoparticle treatment is showing promise for glioblastoma, one of the most aggressive forms of brain cancer.

Janusz Racz, a 67-year-old lung cancer patient, is the first to receive this groundbreaking vaccine. He is part of a cli...
25/08/2024

Janusz Racz, a 67-year-old lung cancer patient, is the first to receive this groundbreaking vaccine. He is part of a clinical trial that is taking place across multiple countries.

BioNTech, a German biotechnology firm, has developed this mRNA-based vaccine dubbed BNT116. The vaccine works by activating the immune system, which then recognizes and combats cancer cells

Janusz Racz, 67, from London, is the first participant to receive the BioNTech vaccine at UCLH.

Researchers at the Karolinska Institutet have recently developed a nanorobot system capable of killing cancer cells in m...
22/08/2024

Researchers at the Karolinska Institutet have recently developed a nanorobot system capable of killing cancer cells in mice.

Researchers at Karolinska Institutet have developed nanorobots that kill cancer cells in mice. The robot’s weapon is hidden in a nanostructure and is exposed only in the tumour microenvironment, sparing healthy cells. The study is published in the journal Nature Nanotechnology.

Address

Thiruvananthapuram

Alerts

Be the first to know and let us send you an email when CAResearchers7- Cancer Research & Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CAResearchers7- Cancer Research & Foundation:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

CAResearchers7 Team and Foundation

As a part of CAResearchers7 Team’s commitment towards Cancer awareness and upbringing of an informed generation. We will be posting about various aspects of Cancer, Range of causes, Prevention strategies and so on.....We hope this will be an eye opener for everyone and pray that everyone adapts to the positive in the mere future. This foundation also provides a free forum for raising questions regarding Cancer, Cancer Pathology, Science, Debating, Spreading Ideas and Concepts and ways of implementation in topics related to Medicine, Biology, Treatment strategies and Technology related to medicine and Cancer.